Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve financial results for ....
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Valiant Laboratories Ltd has informed BSE and NSE that a Board meeting is scheduled for May 14, 2026 to consider and approve the Standalone and Consolidated Audited Financial Results for the quarter and year ended March 31, 2026. The company has also confirmed that the Trading Window has been closed since March 26, 2026 and will remain closed till May 16, 2026, in compliance with SEBI Insider Trading Regulations. This is a standard regulatory intimation under Regulation 29 of SEBI (LODR) Regulations, 2015.
This is a routine meeting notice - no actual financial results or significant corporate developments are being disclosed at this stage. The actual financial performance will be known only after the board meeting approves the results.